Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

12.14
-0.2400-1.94%
Volume:51.46K
Turnover:626.87K
Market Cap:2.12B
PE:120.26
High:12.44
Open:12.44
Low:12.09
Close:12.38
52wk High:18.30
52wk Low:9.77
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.76
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1010
EPS(LYR):2.60
ROE:1.46%
ROA:-1.24%
PB:1.68
PE(LYR):4.67

Loading ...

HUTCHMED (China) (HCM) Receives a Buy from BOCOM International Holdings Company

TIPRANKS
·
Mar 11

HUTCHMED Faces Dual Setbacks: New Drug Withdrawn, Core Products Decline

Deep News
·
Mar 11

When Annual Report Meets Drug Withdrawal: Can HUTCHMED (00013) Break Its 20 Billion Valuation Stalemate?

Stock News
·
Mar 10

Hua Yuan Securities Reiterates "Buy" on HUTCHMED (00013), Sees Promise in ATTC Pipeline

Stock News
·
Mar 10

Asure Hosting Fireside Chat on Its Latest Perspective on Artificial Intelligence

GlobeNewswire
·
Mar 10

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy

GlobeNewswire
·
Mar 09

Hutchmed to Withdraw Cancer Drug in China

MT Newswires Live
·
Mar 09

HUTCHMED Commences Tazverik® Withdrawal and Product Recall

Stock News
·
Mar 09

Hutchmed discontinues all active tazemetostat clinical trials

TIPRANKS
·
Mar 09

CLSA Trims HUTCHMED Target Price to HK$30.40, Keeps Outperform Rating

Stock News
·
Mar 09

Guotai Haitong Sticks to Its Buy Rating for HUTCHMED (China) (HCM)

TIPRANKS
·
Mar 09

HUTCHMED Announces Executive Reshuffle: Dr. Yansi Ya to Assume Senior and Lead Independent Director Role

Stock News
·
Mar 06

Daiwa Capital Markets Adjusts HUTCHMED Target Price to HK$26, Citing Consistent Annual Performance

Stock News
·
Mar 06

Hong Kong Market Announcement Highlights | JD Group Reports 13% Revenue Growth to 1.3091 Trillion Yuan for 2025

Stock News
·
Mar 06

Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates

GlobeNewswire
·
Mar 05

Hutchmed 2025 Earnings Rise, Revenue Falls

MT Newswires Live
·
Mar 05

HUTCHMED Reports 2025 Financial Results with $457 Million Net Profit Attributable to Shareholders

Stock News
·
Mar 05

Earnings Flash (HCM) Hutchmed Posts 2025 Total Revenue $548.5M, vs. FactSet Est of $563.7M

MT Newswires Live
·
Mar 05

Press Release: HUTCHMED Reports 2025 Full Year Results and Business Updates

Dow Jones
·
Mar 05

Hutchmed Launches Global Trial of HMPL-A580 in Patients With Solid Tumors

MT Newswires Live
·
Mar 04